BLLN.US BillionToOne, Inc. Class A Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
116.09 USD
Close of Nov 14, 2026
61.96 150.44
Market cap
USD 5.02B
P/E
114.3x
P/B
9.35x
ROE
10.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BLLN.US undervalued?

Graham number

The Graham number of BillionToOne, Inc. Class A Common Stock cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BillionToOne, Inc. Class A Common Stock fundamental analysis

No fundamental analysis for BillionToOne, Inc. Class A Common Stock yet.

BillionToOne, Inc. Class A Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BillionToOne, Inc. Class A Common Stock

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy t…

Full company profile